ATM and TP53 mutations show mutual exclusivity but distinct clinical impact in mantle cell lymphoma patients

LEUKEMIA & LYMPHOMA

Mareckova, A; Malcikova, J; Tom, N; Pal, K; Radova, L; Salek, D; Janikova, A; Moulis, M; Smardova, J; Kren, L; Mayer, J; Trbusek, M, 2019: ATM and TP53 mutations show mutual exclusivity but distinct clinical impact in mantle cell lymphoma patients. LEUKEMIA & LYMPHOMA 60(6), p. 1420 - 1428, doi: 10.1080/10428194.2018.1542144

Research Groups:

CF: Genomics Core Facility

CEITEC authors:

Lenka Radová, Ph.D.